FR225659-binding
Proteins FR225659 was originally isolated as a novel gluconeogenesis inhibitor produced by fungal strain Helicomyces sp. No. 19353 . To identify the target protein of FR225659, we synthesized high-performance affinity latex beads that immobilized FR225659 derivative FR253761 or FR259383. Using these beads, we identified FR225659 binding proteins as serine/threonine protein phosphatase type 1 (PP1) and type2A (PP2A) from rat hepatocyte crude extract. FR225659 and its synthetic derivatives were strongly inhibited the enzyme activities of purified catalytic subunits of PP1 and PP2A in vitro. and can be reacted with amino group to load ligands. Furthermore, the large total surface area is especially effective in purifying the receptor from a small amount of cell lysate. We have recently reported that receptor purification of a small molecules such as E-3330 and FK506 using this latex particles4).
FR225659
(1) was originally isolated as potent gluconeogenesis inhibitor produced fungal strain Helicomyces sp. No. 193535) . This compound possesses a very unique structure that consists of a novel acyl-group and three unusual amino acids6). 1 inhibits glucagonstimulated gluconeogenesis in primary rat hepatocytes in vitro, and shows hypoglycemic activity in two different in vivo models7). This compound does not inhibit two major rate limiting enzymes of gluconeogenesis pathway, i.e.
glucose-6-phosphatase and fructose-1,6-bisphosphatase. 1 also does not interfere the binding of glucagon and its cell surface receptor. So the target molecule of 1 is still unclear.
For the aim of target molecule identification of 1, we synthesized bioactive derivatives of 1, FR253761 (2), FR259383 (3) and FR259384 (4) (Fig. 1) , and prepared high-performance affinity beads that immobilized 2 or 3 previously8). Using these beads we screened binding proteins of 1 from rat hepatocyte crude extract. We describe here, identification of 1 binding proteins as serine/threonine protein phosphatase type 1 (PP1) and type2A (PP2A), and direct inhibition of PP1 and PP2A enzyme activity by 1 and its synthetic derivatives.
Materials and Methods

Preparation of Rat Hepatocyte Extracts
Rat hepatocytes were isolated by the collagenase perfusion method9) for 24 hour fasted male Wister rats (200-220g). Nuclear extract and cytoplasmic fraction of hepatocytes were prepared as described10).
In Vitro Gluconeogenesis Assay Measurement of in vitro gluconeogenesis activities of isolated rat hepatocyte was described previously7).
Preparation of Drug Immobilized Matrices
Latex beads for affinity purification (SG beads) was prepared as described previously1). Chemical synthesis of compound 2, 3 and 4, plus preparation of latex beads which immobilized 2 or 3 were previously described8). The amount of immobilization of 2 or 3 on latex beads were 38.9nmol/mg or 15.0nmol/mg, respectively.
Affinity Purification of Drug Binding Proteins 0.1mg of latex beads which immobilized 2 or 3 were equilibrated with buffer E (10mM Tris-HCl pH 7.4, 100mM
NaCl, 1mM MgCl2, 0.2mM EDTA, 10% Glycerol, 0.1% Nonidet P-40, 1mM CaCl2, 0.5mM DTT), mixed with buffer E, binding proteins were eluted with SDSpolyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and subjected to 12.5% SDS-PAGE followed by silver staining. For competition analysis, cytoplasmic fraction or nuclear extract was pre-incubated with indicated agitation followed by affinity purified. To estimate the binding proteins, protein bands that competes free ligands were digested with trypsin, followed by peptide-mass fingerprinting was performed using metrics-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Immunoblotting
Immunoblotting was performed as described11) using subunit and anti-PP2A regulatory subunit (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Protein Phosphatase Assay
Purified catalytic subunits of PP1 and PP2A were purchased from Upstate Biotechnology, Inc (Lake Placid, NY). Okadaic acid were purchased from Sigma Chemical
Co. (St. Louis, MO). Protein phosphatase activities were phosphorylase a as substrate and assayed according to previously described procedure12).
Results
Inhibition of Hepatic Gluconeogenesis
The abilities of 1, 2, 3 and 4 to inhibit glucagonstimulated guconeogenesis in primary rat hepatocytes in vitro are summarized in Table 1 . The 50% inhibitory synthetic derivatives could also bind to the target molecule of 1 in similar concentration.
Affinity Purification of Drug Binding Proteins Fig. 2A shows the existence three peptides which specifically binds to 2 immobilized latex beads and these binding are dose dependently competed by the addition of free 1 in rat hepatocyte cytoplasmic fraction (indicated solid arrows). Presumed molecular weight of these peptides are 36kDa, 37kDa, and 60kDa. As the result of peptide mass finger printing, we estimated these proteins were PP1 catalytic subunits (PP1Cs), PP2A catalytic subunit and PP2A regulatory subunit (Fig 2B) .
Immunoblot Analysis
Immunoblot analysis indicated that these peptides which Table 1 . Inhibitory effects of 1, 2, 3 and 4 on glucagon induced gluconeogenesis. cytoplasmic fraction was incubated in the presence (lanes 3-6) or absence (lanes 1, 2) of 1. Then 0.1mg of 2 washed and analyzed 12.5% SDS-PAGE followed by silver staining.
(B) Estimation of 1 binding proteins as serine/threonine protein phosphatase type 1 catalytic subunits (PP1Cs), type2A (PP2A) catalytic subunit and PP2A regulatory subunit by peptide-mass fingerprinting. group of lysine residue and amine spacer attached to carboxy-terminal phenolic hydroxyl group), we prepared 4 immobilized latex followed by deprotection of Boc group to prepare 3 immobilized latex8). All synthetic compounds possess inhibitory activities against glucagon induced gluconeogenesis in vitro (Table. 1). Although in vitro activities of 2, 3 or 4 are less effective than 1, we think it would be enough to identify their binding proteins.
Using the latex beads immobilized 2, we screened binding proteins from crude rat liver extract. From cytoplasmic fraction, we detected three peptides which bind to specifically 2 immobilized latex. Their binding to the latex is competed with free compound 1 by concentration dependent manner ( Fig. 2A indicated solid arrows) . The same result was obtained that compound 2 was used for competition. As results of peptide-mass finger printing, we estimated these proteins were PP1Cs, PP2A catalytic subunit and PP2A regulatory subunit (Fig. 2B) . On the other hand, from rat liver nuclear extract, only putative PP1C peptides seems to bind to affinity beads (data not shown). When used the affinity latex immobilized 3, we detected essentially the same peptides in cytoplasmic fraction and nuclear extract which compete free 1 or 3 by concentrate dependent manner (data not shown).
Immunoblot analysis used specific antibodies for PP1C (Fig. 3 lane 3, 4) . This result indicates binding affinity to PP2A subunits of 2 is much weaker than 1, and is parallel to the IC50 values of PP2A inhibition of these compounds (Table 2) . Similar results were obtained when using 3 immobilized latex beads (data not shown).
To clarify that compound 1, and its synthetic analogues affect to enzymatic activities of PP1 or PP2A catalytic subunits, we assayed inhibitory effects of phosphatase activity purified PP1 or PP2A catalytic subunits. As indicated in Table 2 , all compounds strongly inhibited protein phosphatase activities of PP1 and PP2A when 32P-labelled glycogen phosphorylase a as substrate. According to the ratio of IC50 value of PP1 and PP2A, compound 1 to 4 are more specific inhibitor to PP1 than PP2A. Especially, synthetic derivatives 2, 3 and 4 are extremely specific to PP1 with the ratio of IC50 ranged 600 to 1500. In comparison with gluconeogenesis inhibitory activity summarized in Table 1 , specific inhibition of PP1 may be more critical for inhibition of hepatic gluconeogenesis. The novel gluconeogenesis inhibitors FR225659 and
